切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 90 -93. doi: 10.3877/cma.j.issn.1674-3946.2020.01.026

所属专题: 文献

论著

三种肝切除术治疗肝细胞癌患者的临床疗效对比分析
菅学强1,(), 宋春国1, 李伟2   
  1. 1. 251800 山东阳信,山东省阳信人民医院普外科
    2. 100080 北京,北京市海淀医院普外科
  • 收稿日期:2019-05-13 出版日期:2020-02-26
  • 通信作者: 菅学强

A comparative analysis of clinical efficacy of three hepatectomy for hepatocellular carcinoma

Xueqiang Jian1,(), Chunguo Song1, Wei Li2   

  1. 1. Department of General Surgery, Shandong Yangxin peopleundefineds Hospital, Shandong Yangxin 251800, China
    2. Department of General Surgery, Beijing haidian hospital, Beijing 100080, China
  • Received:2019-05-13 Published:2020-02-26
  • Corresponding author: Xueqiang Jian
  • About author:
    Corresponding author: Jian Xueqiang, Email:
引用本文:

菅学强, 宋春国, 李伟. 三种肝切除术治疗肝细胞癌患者的临床疗效对比分析[J/OL]. 中华普外科手术学杂志(电子版), 2020, 14(01): 90-93.

Xueqiang Jian, Chunguo Song, Wei Li. A comparative analysis of clinical efficacy of three hepatectomy for hepatocellular carcinoma[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2020, 14(01): 90-93.

目的

探讨3D腹腔镜下肝切除术治疗肝细胞癌的近远期疗效。

方法

回顾性分析2014年1月至2016年12月收治的肝细胞癌患者96例,根据术式不同分为3D组32例,2D组47例和开腹组17例。采用SPSS 13.0进行数据分析,术中术后相关指标、血清生物学指标计量资料以(±s)表示,多组比较采用方差分析;术后并发症、肿瘤复发率及生存率比较采用χ2检验,P<0.05差异有统计学意义。

结果

3D组术中失血量、术后引流管时间、切口长度及术后住院时间均小于2D腹腔镜组及开腹组(P<0.05);3D组并发症发生率(9.4%)低于2D组(19.1%)及开腹组(47.1%),P<0.05;术后第3天,ET、IL-6、IL-8、CRP血浆水平均下降,3D组<2D组<开腹组(P<0.05);术后1年无复发生存率、术后1年生存率、术后2年无复发生存率、术后2年生存率三组差异无统计学意义(P>0.05)。

结论

3D腹腔镜下肝切除术治疗肝细胞癌患者术后炎症反应较轻,机体损伤小,近期疗效显著,远期疗效相当,具有较高的临床价值。

Objective

To explore the short-term and long-term effect of 3D laparoscopic hepatectomy for the hepatocellular carcinoma.

Methods

96 patients with the hepatocellular carcinoma from January 2014 to December 2016 were analyzed retrospectively. According to the different operative procedure, they were divided into a 3-D group (32 cases), a 2-D group (47 cases) and a laparotomy group (17 cases). SPSS 13.0 was used to analyze, and the measurement data of intraoperative and postoperative related indexes and serum biological indexes were expressed with (±s), and the analysis of variance was used for comparison of multiple groups; χ2 test was used for comparison of postoperative complications, tumor recurrence rate and survival rate. There was statistical significance when the P<0.05.

Results

The blood loss, drainage time, incision length and hospital stay in the 3D group were less than those in the 2D laparoscopy group and laparotomy group (P<0.05); the incidence of complications in 3D group (9.4%) was lower than those in the 2D group (19.1%) and laparotomy group (47.1%) (P<0.05); the decline range of ET, IL-6, IL-8 and CRP on the third day after operation in 3D group was lower than this in the 2D group and the laparotomy group (P<0.05). There was no significant difference in survival rate, 1-year survival rate, 2-year recurrence free survival rate and 2-year survival rate between the three groups (P>0.05).

Conclusion

The treatment of 3D laparoscopic hepatectomy has high clinical value in the treatment of hepatocellular carcinoma, because of its light postoperative inflammatory response, small body damage, significant short-term effect and similar long-term effect.

表1 96例HCC患者不同术式三组患者一般资料比较[例,(±s)]
表2 96例HCC患者不同术式三组患者手术相关指标比较(±s)
表3 96例HCC患者不同术式三组患者术后并发症比较[例(%)]
表4 96例HCC患者不同术式三组血清学生物指标比较(±s)
表5 96例HCC患者不同术式三组肿瘤复发率及生存率比较[例(%)]
[1]
Sayiner M, Golabi P, Younossi ZM.Disease burden of hepatocellular carcinoma: A global perspective[J].Dig Dis Sci,2019,64(4):910-917.
[2]
欧阳正晟,唐朝晖,吕丽娟,等.腹腔镜肝切除与开腹肝切除治疗原发性肝癌的临床比较[J].中国普通外科杂志,2017,26(1):126-130.
[3]
Virgilio E, Scorsi A, Amodio PM,et al.Port Site Recurrences Following Laparoscopic Liver Resection for Hepatocellular Carcinoma[J]. World J Surg,2016,40(7):1778-1779.
[4]
Witowski J, Rubinkiewicz M, Mizera M,et al.Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients[J].Surg Endosc,2019,33(5):1491-1507.
[5]
Vega EA, Kutlu OC, Joechle K,et al.Preoperative prognosticators of safe laparoscopic hepatocellular carcinoma resection in advanced cirrhosis: a propensity score matching population-based analysis of 1799 western patients[J]. J Gastrointest Surg,2019,23(6):1157-1165.
[6]
Ciria R, Cherqui D, Geller DA,et al.Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing[J].Ann Surg,2016,263(4):761-777.
[7]
Agrusa A, di Buono G, Chianetta D,et al.Three-dimensional ( 3D) versus two-dimensional ( 2D) laparoscopic adrenalectomy:A case control study[J].Int J Surg,2016,28( Suppl 1):S114-S117.
[8]
王笛乐,屈碧辉,胡敏,等.3D腹腔镜肝切除术治疗原发性肝癌的临床应用价值[J].中国普通外科杂志,2017,26(1):13-17.
[9]
中华人民共和国卫生部.原发性肝癌诊疗规范(2011版)[J].临床肿瘤学杂志,2011,16(10):929-946.
[10]
陈孝平,张志伟,杨甲梅,等.原发性肝癌外科治疗方法的选择[J].中华肝脏病杂志,2005,13(5):329-330.
[11]
梅俊.腹腔镜肝切除与开腹肝切除治疗原发性肝细胞癌临床研究[J].肝胆外科杂志,2018,26(1):23-26.
[12]
Cheung TT, Ma KW, She WH,et al.Pure laparoscopic hepatectomy with augmented reality-assisted indocyanine green fluorescence versus open hepatectomy for hepatocellular carcinoma with liver cirrhosis: A propensity analysis at a single center[J]. Asian J Endosc Surg,2018,11(2):104-111.
[13]
Jiang B, Yan XF, Zhang JH.Meta-analysis of laparoscopic versus open liver resection for hepatocellular carcinoma[J].Hepatol Res,2018,48(8):635-663.
[14]
El Boghdady M, Ramakrishnan G, Tang B,et al. A Comparative Study of Generic Visual Components of Two-Dimensional Versus Three-Dimensional Laparoscopic Images[J].World J Surg,2018,42(3):688-694.
[15]
Kawai T, Goumard C, Jeune F,et al.3D vision and maintenance of stable pneumoperitoneum: a new step in the development of laparoscopic right hepatectomy[J]. Surg Endosc,2018,32(8):3706-3712.
[16]
中华医学会外科学分会腹腔镜与内镜外科学组.3D腹腔镜手术技术专家共识[J].中国实用外科杂志,2015,35(9):967-969.
[17]
杨成林,张书培.3D/2D腹腔镜根治术与开腹术治疗原发性肝癌的疗效及细胞免疫变化比较[J/CD].中华普外科手术学杂志(电子版),2018,12(5): 382-384.
[18]
Zou M, Xi L, Rao J,et al. [Optimization and evaluation of an inflammatory cell model in LPS-stimulated PMA-differentiated THP-1 cells][J].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi,2017,33(11):1456-1461.
[19]
Fox BM, Becker BK, Loria AS,et al. Acute Pressor Response to Psychosocial Stress Is Dependent on Endothelium-Derived Endothelin-1[J]. J Am Heart Assoc,2018,7(4):e007863.
[1] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[2] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[3] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[4] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[5] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[6] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[7] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[8] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[9] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[10] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[11] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[12] 韩戟, 杨力, 陈玉. 腹部形态CT参数与完全腹腔镜全胃切除术术中失血量的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 88-91.
[13] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[14] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[15] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
阅读次数
全文


摘要